Non-Current Liabilities

Finance Lease Liabilities (Total)

Regeneron Pharmaceuticals Finance Lease Liabilities (Total) remained flat by 0.0% to $720.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $720.00M to $720.00M. Over 5 years (FY 2020 to FY 2025), Finance Lease Liabilities (Total) shows relatively stable performance with a 0.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2025Feb 4, 2026

How to read this metric

An increase indicates higher reliance on lease-based financing for long-term assets, which increases fixed financial obligations and leverage ratios.

Detailed definition

This represents the present value of future lease payments for assets where the lease term covers a major part of the as...

Peer comparison

Comparable to debt obligations, this metric is analyzed alongside long-term borrowings to assess the total capital structure and financial risk profile of peer energy companies.

Metric ID: finance_lease_liabilities_total

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$719.70M$720.00M$720.00M$720.00M$720.00M
QoQ Change+0.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.0%+0.0%
Range$719.70M$720.00M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak4+ quarters growth

Finance Lease Liabilities (Total) at Other Companies

Frequently Asked Questions

What is Regeneron Pharmaceuticals's finance lease liabilities (total)?
Regeneron Pharmaceuticals (REGN) reported finance lease liabilities (total) of $720.00M in Q4 2025.
How has Regeneron Pharmaceuticals's finance lease liabilities (total) changed year-over-year?
Regeneron Pharmaceuticals's finance lease liabilities (total) decreased by 0.0% year-over-year, from $720.00M to $720.00M.
What is the long-term trend for Regeneron Pharmaceuticals's finance lease liabilities (total)?
Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's finance lease liabilities (total) has grown at a 0.1% compound annual growth rate (CAGR), from $717.20M to $720.00M.
What does finance lease liabilities (total) mean?
The total present value of future payments for leased assets that are essentially treated as debt-financed purchases.